Gao H, Zhao D, Li C, Deng M, Li G, Chen S
Molecules. 2025; 30(3).
PMID: 39942606
PMC: 11820035.
DOI: 10.3390/molecules30030503.
Hicks P, Manzoni T, Westover J, Petch R, Roper B, Gowen B
Vaccines (Basel). 2025; 12(12.
PMID: 39772063
PMC: 11728676.
DOI: 10.3390/vaccines12121403.
Zhang S, Shang H, Han S, Li J, Peng X, Wu Y
EBioMedicine. 2024; 111():105481.
PMID: 39644769
PMC: 11665701.
DOI: 10.1016/j.ebiom.2024.105481.
Chen Z, Zhang J, Wang J, Tong H, Pan W, Ma F
PLoS Pathog. 2024; 20(11):e1012725.
PMID: 39585899
PMC: 11627400.
DOI: 10.1371/journal.ppat.1012725.
Qian H, Tian L, Liu W, Liu L, Li M, Zhao Z
NPJ Vaccines. 2024; 9(1):194.
PMID: 39426985
PMC: 11490641.
DOI: 10.1038/s41541-024-00993-y.
Making Rift Valley Fever Viral Particles Fluorescent.
Gu Y, Koch J, Garnier C, Erny A, Lozach P
Methods Mol Biol. 2024; 2824:165-188.
PMID: 39039413
DOI: 10.1007/978-1-0716-3926-9_12.
Expression and Purification of RVFV Glycoprotein C for Structural Studies Using Baculovirus Expression System.
Tiwari S, Dessau M
Methods Mol Biol. 2024; 2824:121-133.
PMID: 39039410
DOI: 10.1007/978-1-0716-3926-9_9.
Identification and characterization of three monoclonal antibodies targeting the SFTSV glycoprotein and displaying a broad spectrum recognition of SFTSV-related viruses.
Wu X, Moming A, Zhang Y, Wang Z, Zhang T, Fu L
PLoS Negl Trop Dis. 2024; 18(6):e0012216.
PMID: 38848311
PMC: 11161016.
DOI: 10.1371/journal.pntd.0012216.
Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model.
Chang Z, Gao D, Liao L, Sun J, Zhang G, Zhang X
Proc Natl Acad Sci U S A. 2024; 121(24):e2400163121.
PMID: 38830098
PMC: 11181109.
DOI: 10.1073/pnas.2400163121.
Characterization of antibodies targeting severe fever with thrombocytopenia syndrome virus glycoprotein Gc.
Sano K, Kimura M, Sataka A, Hasegawa H, Tani H, Suzuki T
Arch Virol. 2024; 169(3):40.
PMID: 38308735
DOI: 10.1007/s00705-024-05968-x.
Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development.
Kim D, Lai C, Cha I, Jung J
Viruses. 2024; 16(1).
PMID: 38257828
PMC: 10818334.
DOI: 10.3390/v16010128.
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus.
Alkan C, OBrien T, Kenyon V, Ikegami T
Viruses. 2024; 16(1).
PMID: 38257788
PMC: 10818293.
DOI: 10.3390/v16010088.
Potent immunogenicity and neutralization of recombinant adeno-associated virus expressing the glycoprotein of severe fever with thrombocytopenia virus.
Shimoyama T, Oba M, Takemae H, Omatsu T, Tani H, Mizutani T
J Vet Med Sci. 2023; 86(2):228-238.
PMID: 38143087
PMC: 10898983.
DOI: 10.1292/jvms.23-0375.
Humoral immunity to phlebovirus infection.
Doores K
Ann N Y Acad Sci. 2023; 1530(1):23-31.
PMID: 37936483
PMC: 10952791.
DOI: 10.1111/nyas.15080.
The Neutralizing Monoclonal Antibodies against SFTS Group Bandaviruses Suggest New Targets of Specific or Broad-Spectrum Antivirals.
Fu L, Xu L, Qian J, Wu X, Wang Z, Wang H
Am J Trop Med Hyg. 2023; 109(6):1319-1328.
PMID: 37931293
PMC: 10793057.
DOI: 10.4269/ajtmh.23-0073.
Severe fever with thrombocytopenia syndrome virus genotype B in Thailand.
Rattanakomol P, Khongwichit S, Chuchaona W, Vongpunsawad S, Poovorawan Y
Arch Virol. 2023; 168(11):271.
PMID: 37833439
DOI: 10.1007/s00705-023-05897-1.
Host entry factors of Rift Valley Fever Virus infection.
Ganaie S, Leung D, Hartman A, Amarasinghe G
Adv Virus Res. 2023; 117():121-136.
PMID: 37832991
PMC: 11312830.
DOI: 10.1016/bs.aivir.2023.09.001.
Cryo-EM structure of severe fever with thrombocytopenia syndrome virus.
Du S, Peng R, Xu W, Qu X, Wang Y, Wang J
Nat Commun. 2023; 14(1):6333.
PMID: 37816705
PMC: 10564799.
DOI: 10.1038/s41467-023-41804-7.
Organisation of the orthobunyavirus tripodal spike and the structural changes induced by low pH and K during entry.
Hover S, Charlton F, Hellert J, Swanson J, Mankouri J, Barr J
Nat Commun. 2023; 14(1):5885.
PMID: 37735161
PMC: 10514341.
DOI: 10.1038/s41467-023-41205-w.
The phenuivirus Toscana virus makes an atypical use of vacuolar acidity to enter host cells.
Koch J, Xin Q, Obr M, Schafer A, Rolfs N, Anagho H
PLoS Pathog. 2023; 19(8):e1011562.
PMID: 37578957
PMC: 10449198.
DOI: 10.1371/journal.ppat.1011562.